Antibody optimization enabled by artificial intelligence predictions of binding affinity and naturalness
Open accessThe DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
Traditional antibody optimization approaches involve screening a small subset of the available sequence space, often resulting in drug candidates with suboptimal binding affinity, developability or immunogenicity. Based on two distinct antibodies, we demonstrate that deep contextual language models trained on high-throughput affinity data can quantitatively predict binding of unseen antibody sequence variants. These variants span a K D range of three orders of magnitude over a large mutational space. Our models reveal strong epistatic effects, which highlight the need for intelligent screening approaches. In addition, we introduce the modeling of “naturalness”, a metric that scores antibody variants for similarity to natural immunoglobulins. We show that naturalness is associated with measures of drug developability and immunogenicity, and that it can be optimized alongside binding affinity using a genetic algorithm. This approach promises to accelerate and improve antibody engineering, and may increase the success rate in developing novel antibody and related drug candidates.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MultiQC: summarize analysis results for multiple tools and samples in a single report
Ewels, P., Magnusson, M., Lundin, S., & Käller, M. (2016) · Bioinformatics · doi:10.1093/bioinformatics/btw354 · Cited by 10,143
Biopython: freely available python tools for computational molecular biology and bioinformatics
Cock, P. J. A., Antao, T., Chang, J. T., Chapman, B. A., Cox, C. J., Dalke, A., Friedberg, I., Hamelryck, T., Kauff, F., Wilczynski, B., et al. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp163 · Cited by 6,080 · cited 1×
“Alignment was performed using the Needleman–Wunsch algorithm implemented in Biopython [40], with the following parameters: PairwiseAligner, mode=global, match_score=5, mismatch_score=-4, open_gap_score=-20, extend_gap_score=-1 .”
MethodHow to improve R&D productivity: the pharmaceutical industry's grand challenge
Paul, S. M., Mytelka, D. S., Dunwiddie, C. T., Persinger, C. C., Munos, B. H., Lindborg, S. R., & Schacht, A. L. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3078 · Cited by 3,566
Rives, A., Meier, J., Sercu, T., Goyal, S., Lin, Z., Liu, J., Guo, D., Ott, M., Zitnick, C. L., Ma, J., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2016239118 · Cited by 3,286
Self-citationRives, A., Meier, J., Sercu, T., Goyal, S., Lin, Z., Liu, J., Guo, D., Ott, M., Zitnick, C. L., Ma, J., et al. (2019) · doi:10.1101/622803 · Cited by 3,280
Self-citationPrinciples of early drug discovery
Hughes, J., Rees, S., Kalindjian, S., & Philpott, K. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01127.x · Cited by 2,859
Density-Based Clustering Based on Hierarchical Density Estimates
Campello, R. J. G. B., Moulavi, D., & Sander, J. (2013) · Lecture Notes in Computer Science · doi:10.1007/978-3-642-37456-2_14 · Cited by 2,680
Unified rational protein engineering with sequence-based deep representation learning
Alley, E. C., Khimulya, G., Biswas, S., AlQuraishi, M., & Church, G. M. (2019) · Nature Methods · doi:10.1038/s41592-019-0598-1 · Cited by 1,131
Biophysical properties of the clinical-stage antibody landscape
Jain, T., Sun, T., Durand, S., Hall, A., Houston, N. R., Nett, J. H., Sharkey, B., Bobrowicz, B., Caffry, I., Yu, Y., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1616408114 · Cited by 629
Low-N protein engineering with data-efficient deep learning
Biswas, S., Khimulya, G., Alley, E. C., Esvelt, K. M., & Church, G. M. (2021) · Nature Methods · doi:10.1038/s41592-021-01100-y · Cited by 422
Five computational developability guidelines for therapeutic antibody profiling
Raybould, M. I. J., Marks, C., Krawczyk, K., Taddese, B., Nowak, J., Lewis, A. P., Bujotzek, A., Shi, J., & Deane, C. M. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1810576116 · Cited by 357
Olsen, T. H., Boyles, F., & Deane, C. M. (2022) · Protein Science · doi:10.1002/pro.4205 · Cited by 319
Mason, D. M., Friedensohn, S., Weber, C. R., Jordi, C., Wagner, B., Meng, S. M., Ehling, R. A., Bonati, L., Dahinden, J., Gainza, P., et al. (2021) · Nature Biomedical Engineering · doi:10.1038/s41551-021-00699-9 · Cited by 308
Antibody structure prediction using interpretable deep learning
Ruffolo, J. A., Sulam, J., & Gray, J. J. (2022) · Patterns · doi:10.1016/j.patter.2021.100406 · Cited by 216
Antibody complementarity determining region design using high-capacity machine learning
Liu, G., Zeng, H., Mueller, J., Carter, B., Wang, Z., Schilz, J., Horny, G., Birnbaum, M. E., Ewert, S., & Gifford, D. K. (2020) · Bioinformatics · doi:10.1093/bioinformatics/btz895 · Cited by 157 · cited 3×
“[30], which we refer 950 to as the Gifford Library).”
BackgroundLuo, S., Su, Y., Peng, X., Wang, S., Peng, J., & Ma, J. (2022) · doi:10.1101/2022.07.10.499510 · Cited by 151
Saka, K., Kakuzaki, T., Metsugi, S., Kashiwagi, D., Yoshida, K., Wada, M., Tsunoda, H., & Teramoto, R. (2021) · Scientific Reports · doi:10.1038/s41598-021-85274-7 · Cited by 144 · cited 1×
“Several promising approaches have been proposed [8–14], but only two 26 studies have had in silico predictions validated in the lab [15,16].”
BackgroundMeasuring the sequence-affinity landscape of antibodies with massively parallel titration curves
Adams, R. M., Mora, T., Walczak, A. M., & Kinney, J. B. (2016) · eLife · doi:10.7554/elife.23156 · Cited by 137
Humanization of antibodies using a machine learning approach on large-scale repertoire data
Marks, C., Hummer, A. M., Chin, M., & Deane, C. M. (2021) · Bioinformatics · doi:10.1093/bioinformatics/btab434 · Cited by 124 · cited 2×
“We investigated the latter because their reported immunogenicity is 351 greater [29], thereby providing an ideal case study.”
BackgroundDLAB-deep learning methods for structure-based virtual screening of antibodies
Schneider, C., Buchanan, A., Taddese, B., & Deane, C. M. (2022) · Bioinformatics · doi:10.1093/bioinformatics/btab660 · Cited by 102 · cited 1×
“22 Deep neural networks are an emerging tool that can help overcome the limitations of 23 experimental screening capacity [7].”
BackgroundHallucinating structure-conditioned antibody libraries for target-specific binders
Mahajan, S. P., Ruffolo, J. A., Frick, R., & Gray, J. J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.999034 · Cited by 20
Cited by
The Dawn of a New Era: Targeting the “Undruggables” with Antibody-Based Therapeutics
Qian, L., Lin, X., Gao, X., Khan, R. U., Liao, J.-Y., Du, S., Ge, J., Zeng, S., & Yao, S. Q. (2023) · Chemical Reviews · doi:10.1021/acs.chemrev.2c00915 · Cited by 155
Designing diverse and high-performance proteins with a large language model in the loop
Gomez-Uribe, C. A., Gado, J., & Islamov, M. (2025) · PLOS Computational Biology · doi:10.1371/journal.pcbi.1013119 · Cited by 6
How well do contextual protein encodings learn structure, function, and evolutionary context?
(2025) · doi:10.1016/j.cels.2025.101201 · Cited by 3
Contextual protein and antibody encodings from equivariant graph transformers
Mahajan, S. P., Ruffolo, J. A., & Gray, J. J. (2023) · doi:10.1101/2023.07.15.549154 · Cited by 3
Metadata
- Authors
- Bachas, S., Rakocevic, G., Spencer, D., Sastry, A. V., Haile, R., Sutton, J. M., Kasun, G., Stachyra, A., Gutierrez, J. M., Yassine, E., Medjo, B., Blay, V., Kohnert, C., Stanton, J. T., Brown, A., Tijanic, N., McCloskey, C., Viazzo, R., Consbruck, R., Carter, H., Levine, S., Abdulhaqq, S., Shaul, J., Ventura, A. B., Olson, R. S., Yapici, E., Meier, J., McClain, S., Weinstock, M., Hannum, G., Schwartz, A., Gander, M., & Spreafico, R.
- Venue
- bioRxiv (Cold Spring Harbor Laboratory)
- Publisher
- openRxiv
- Published
- 2022-08-17
- OpenAlex
- W4400482950
- Cited by
- 62
- References
- 21
- Type
- posted content
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.